Press Releases

AUSTIN, Texas, Oct. 29, 2019 /PRNewswire/ -- As America's number-one pre-workout and fastest-growing energy drink brand, C4® continues to unlock new distribution across the United States. The better-for-you performance energy drink is striking strategic partnerships with a rapidly growing number of large retailers like Safeway&re

AUSTIN, Texas, Oct. 29, 2019 /PRNewswire/ -- L7 Informatics, Inc., a leader in informatics solutions and services for genomic research organizations, is pleased to announce the USDA is

MANASSAS, Va., Oct. 29, 2019 /PRNewswire/ -- ATCC announced the first launch from a portfolio of exosomes (i.e., extracellular vesicles) derived from human cells to serve as reference materials or standards for a variety of research applications. The first two exosomes available to researchers are derived from the A549 non-small cell lung cancer (NSCLC) cell line

PORTLAND, Ore., Oct. 29, 2019 /PRNewswire/ -- Jama Software, the leading development platform provider for building complex products and integrated systems, today announced a series of&nb

NEW YORK, Oct. 29, 2019 /PRNewswire/ -- Questex will bring the life sciences industry together at the

TUCSON, Ariz., Oct. 29, 2019 /PRNewswire/ -- Sabino Recovery is proud to announce and welcome Roy M. Serpa as their new Board Advisor.  Mr. Serpa brings with him over 30 years of experience in Executive Healthcare Leadership and Board advisory support in behavioral healthcare. He has 24 years of experience as a CEO and Board membe

NORTH CHICAGO, Ill., Oct. 29, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced the launch of

SEATTLE, Oct. 29, 2019 /PRNewswire/ -- Accolade, a personalized health and benefits solution for employers, health plans and their members, today announced at the HLTH 2019 conference that it is expand

BALTIMORE, Oct. 29, 2019 /PRNewswire/ -- Illumina, Inc., a leading developer, manufacturer, and marketer of life science tools and integrated systems, celebrated today the grand opening of its new training facility in the University of Maryland (UM) BioPark. The 13,000-square-foot Illumina Solutions Center provides training lab cap

HADDONFIELD, N.J., Oct. 29, 2019 /PRNewswire/ -- Linnaeus Therapeutics, Inc. (Linnaeus), a privately held clinical-stage biopharmaceutical company focused on the development and commercialization of novel small molecule oncology therapeutics, today announced that it has dosed the first patient in its phase 1/2 clinical trial of LNS8801 in patients with advanced